Apr 28, 2021
LivaNova Reports First Quarter 2021 Results
LONDON --(BUSINESS WIRE)--Apr. 28, 2021-- LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2021 . For the first quarter of 2021, worldwide sales from continuing operations were $247.6 million , an
Apr 26, 2021
LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression
LONDON --(BUSINESS WIRE)--Apr. 26, 2021-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Verily, a subsidiary of Alphabet focused on life sciences and healthcare, today announced that the first patient has been enrolled in their collaborative UNCOVER
Apr 20, 2021
LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine
Intuitive, optical-based technology system now available around the world LONDON --(BUSINESS WIRE)--Apr. 20, 2021-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for
Apr 19, 2021
LivaNova Achieves Clinical Milestone in Heart Failure Program
300th patient randomized in ANTHEM-HFrEF pivotal study LONDON --(BUSINESS WIRE)--Apr. 19, 2021-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has randomized the 300th patient in the A uto n omic Regulation Th erapy to E nhance M
Mar 25, 2021
LivaNova to Host Conference Call for First Quarter 2021 Results
LONDON --(BUSINESS WIRE)--Mar. 25, 2021-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first quarter 2021 results on Wednesday, April 28, 2021 at 12 p.m.   London time ( 7 a.m. Eastern Daylight Time ).
Feb 24, 2021
LivaNova Reports Fourth Quarter and Full-Year 2020 Results
LONDON --(BUSINESS WIRE)--Feb. 24, 2021-- LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2020 . For the fourth quarter of 2020, worldwide sales from continuing operations were $269.6
Jan 20, 2021
LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2020 Results
LONDON --(BUSINESS WIRE)--Jan. 20, 2021-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2020 results on Wednesday, February 24, 2021 at 1 p.m.   London time ( 8 a.m.